- Home
- AGM vs CNTA Comparison
AGM vs CNTA Comparison
Compare AGM & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGM
- CNTA
- Stock Information
- Founded
- AGM 1987
- CNTA 2020
- Country
- AGM United States
- CNTA United Kingdom
- Employees
- AGM N/A
- CNTA N/A
- Industry
- AGM Finance Companies
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- AGM Finance
- CNTA Health Care
- Exchange
- AGM Nasdaq
- CNTA Nasdaq
- Market Cap
- AGM 2.2B
- CNTA 2.3B
- IPO Year
- AGM N/A
- CNTA 2021
- Fundamental
- Price
- AGM $199.34
- CNTA $17.16
- Analyst Decision
- AGM Hold
- CNTA Strong Buy
- Analyst Count
- AGM 1
- CNTA 7
- Target Price
- AGM $205.00
- CNTA $23.71
- AVG Volume (30 Days)
- AGM 40.5K
- CNTA 705.7K
- Earning Date
- AGM 11-04-2024
- CNTA 11-12-2024
- Dividend Yield
- AGM 2.81%
- CNTA N/A
- EPS Growth
- AGM 0.71
- CNTA N/A
- EPS
- AGM 15.55
- CNTA N/A
- Revenue
- AGM $347,661,000.00
- CNTA $6,853,000.00
- Revenue This Year
- AGM N/A
- CNTA N/A
- Revenue Next Year
- AGM $6.65
- CNTA N/A
- P/E Ratio
- AGM $12.83
- CNTA N/A
- Revenue Growth
- AGM 2.91
- CNTA N/A
- 52 Week Low
- AGM $169.17
- CNTA $6.65
- 52 Week High
- AGM $217.60
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- AGM 38.95
- CNTA 50.89
- Support Level
- AGM $197.68
- CNTA $16.02
- Resistance Level
- AGM $210.56
- CNTA $18.12
- Average True Range (ATR)
- AGM 4.40
- CNTA 1.08
- MACD
- AGM -2.34
- CNTA -0.08
- Stochastic Oscillator
- AGM 9.55
- CNTA 41.42
About AGM Federal Agricultural Mortgage Corporation
Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Rural Utilities, Renewable Energy, Funding, Investments, and Corporate. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.